Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altaras

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1996
Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogensI Cohen, A Figer, M M Altaras, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 1, 1995
Transvaginal color flow imaging in the diagnosis of ovarian tumorsR Tepper, L Lerner-Geva, M M Altaras, et al.
Gynecologic Oncology|January 1, 1996
Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifenI Cohen, Y Beyth, R Tepper, et al.
Gynecologic Oncology|November 5, 1997
Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologiesI Cohen, Y Beyth, M M Altaras, et al.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1996
Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patientsI Cohen, M M Altaras, J Shapira, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Genes, Chromosomes & Cancer|May 25, 1999
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumoursS J Ramus, L G Bobrow, P D Pharoah, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1996
Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogensI Cohen, A Figer, M M Altaras, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 1, 1995
Transvaginal color flow imaging in the diagnosis of ovarian tumorsR Tepper, L Lerner-Geva, M M Altaras, et al.
Gynecologic Oncology|January 1, 1996
Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifenI Cohen, Y Beyth, R Tepper, et al.
Gynecologic Oncology|November 5, 1997
Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologiesI Cohen, Y Beyth, M M Altaras, et al.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1996
Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patientsI Cohen, M M Altaras, J Shapira, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Genes, Chromosomes & Cancer|May 25, 1999
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumoursS J Ramus, L G Bobrow, P D Pharoah, et al.
Pageof 12